Skip to content
Menu
Blythe Adamson, PhD, MPH
  • Infectious Economics LLC
  • Publications
    • Manuscripts
    • Abstracts
    • Other Articles
    • Speaking
  • Courses
    • Short Course
    • Methods
    • Research
    • Resources
  • Media
    • Press
    • Speaking
  • About
Blythe Adamson, PhD, MPH
February 3, 2017January 24, 2018

Rising cost of HIV drugs

Digging through the Medicaid Prescription Drug Database, I want to find out if HIV drug prices are rising faster over time compared to other daily medications for chronic diseases. I stratified by the number of drugs in each combination tablet, and next I will need to adjust for inflation. Let me know if you think of a good class of comparator drugs.

 

SaveSave

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on Facebook (Opens in new window)

Related

1 thought on “Rising cost of HIV drugs”

  1. Nathaniel says:
    February 7, 2017 at 6:15 pm

    I think the difficulty is that we want to pay for drugs that innovate, and there’s been a lot of innovation in HIV medicines. Perhaps you could match HIV drugs with another class of drugs that has produced a similar amount of improvement in survival times in the same period. It’s hard to think of a class of drugs like that, but off the top of my head I might suggest drugs for CML or hepatitis C.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Top Posts & Pages

  • About
    About
  • Short Courses
    Short Courses
  • Better Health Policy for Successful Live Theater in COVID-19
    Better Health Policy for Successful Live Theater in COVID-19
  • Methods
    Methods
  • Tools for Reproducible Real-World Data Analysis
    Tools for Reproducible Real-World Data Analysis
  • Manuscripts
    Manuscripts
  • Economic roots of COVID-19 racial disparities
    Economic roots of COVID-19 racial disparities
My Tweets
Twitter

Top Posts & Pages

  • About
    About
  • Short Courses
    Short Courses
  • Better Health Policy for Successful Live Theater in COVID-19
    Better Health Policy for Successful Live Theater in COVID-19
  • Methods
    Methods
  • Tools for Reproducible Real-World Data Analysis
    Tools for Reproducible Real-World Data Analysis
  • Manuscripts
    Manuscripts
  • Economic roots of COVID-19 racial disparities
    Economic roots of COVID-19 racial disparities
My Tweets
©2023 Blythe Adamson, PhD, MPH | Powered by WordPress and Superb Themes!
 

Loading Comments...